Search Results 7891-7900 of 36862 for oral

  1. Otolaryngology (ENT)/Head and Neck Surgery - Doctors - Mayo Clinic

    ... Oral surgery, Salivary gland surgery, Throat cancer, Salivary gland cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Melanoma, Tonsil cancer ...

  2. Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery - Mayo Clinic

    ... oral, implanted, or injectable contraceptive hormones or mechanical products such as intrauterine device or barrier methods (diaphragm, condoms, spermicides) ...

  3. Phase IIB Study Of PHENOGENE-1A (Cromolyn) As An Adjuvant Therapy In Mild To Moderate ALS - Mayo Clinic

    Inability to tolerate the administration of an oral inhaled powder via DPI. 9. Has taken any investigational product within 30 days or 5 half lives of the ...

  4. Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction - Mayo Clinic

    Radiation to < 25% of bone marrow. Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 (Karnofsky ≥ 70%); Able to swallow and retain oral ...

  5. Leslie V. Simon, D.O. - Doctors and Medical Staff - Mayo Clinic

    Second Place, Lightning Oral Poster Presentation: &quot;Ultrasound for Fractures&quot;Southeastern Society of Academic Emergency Medicine. 2012. Exemplary ...

  6. Publications - Allan M. Klompas, M.B., B.Ch., BAO - Mayo Clinic

    Contemporary Perioperative Management of Direct Oral Anticoagulants. Adv Anesth. 2022 Dec; 40(1):93-109. View PubMed; Liu VC, Klompas AM, Stulak JM, Yalamuri ...

  7. Mayo Clinic Minute: Alcohol and cancer risk

    Dr. Donald Hensrud says alcohol is the third-leading preventable cause of cancer in the U.S., behind tobacco use and obesity.

  8. Promethazine (injection route, intravenous route) - Side effects & uses - Mayo Clinic

    Your doctor will give you a few doses of this medicine until your condition improves, and then switch you to an oral medicine that works the same way. If ...

  9. Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants - Mayo Clinic

    using oral contraceptives must agree to use an additional birth control method. While not considered highly effective, a double-barrier method is acceptable ...

  10. First In Human Study Of TUB-030 In Patients With Advanced Solid Tumors - Mayo Clinic

    ... oral or investigational drugs must have had their last dose at least 4 weeks (6 weeks for nitrosourea, mitomycin-C) or 5 half-lives, whichever is shorter ...